Bookmark and Share

Compound Summary for: CID 9803963

GW 501516

Also known as: GW501516, 317318-70-0, GW-501516, Endurobol, GSK-516, GW 1516, GW1516, UNII-7I2HA1NU22, CHEBI:73726
Molecular Formula: C21H18F3NO3S2   Molecular Weight: 453.49773   InChIKey: YDBLKRPLXZNVNB-UHFFFAOYSA-N
GW-501516 is a peroxisome proliferator-activator receptor-delta agonist for the potential treatment of dyslipidemia. It is developed by GlaxoSmithKline. This drug is in Phase II clinical trials .   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Biomedical Effects and Toxicity
Literature
Patents
Biological Test Results
Classification
Chemical and Physical Properties
_ _